vs
ABVC BIOPHARMA, INC.（ABVC）与SOCIETY PASS INCORPORATED.（SOPA）财务数据对比。点击上方公司名可切换其他公司
SOCIETY PASS INCORPORATED.的季度营收约是ABVC BIOPHARMA, INC.的1.7倍（$1.4M vs $796.0K），ABVC BIOPHARMA, INC.净利率更高（-256.6% vs -370.8%，领先114.2%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs -17.6%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs -11.2%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
荒野协会是扎根于澳大利亚社区的非营利非政府环保倡导组织，致力于推动环境保护事业，凝聚社会各界力量守护本土自然生态与荒野资源，倡导人与自然和谐共生的发展理念。
ABVC vs SOPA — 直观对比
营收规模更大
SOPA
是对方的1.7倍
$796.0K
营收增速更快
ABVC
高出122.1%
-17.6%
净利率更高
ABVC
高出114.2%
-370.8%
两年增速更快
ABVC
近两年复合增速
-11.2%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $1.4M |
| 净利润 | $-2.0M | $-5.1M |
| 毛利率 | 100.0% | 64.3% |
| 营业利润率 | -246.8% | -379.9% |
| 净利率 | -256.6% | -370.8% |
| 营收同比 | 104.5% | -17.6% |
| 净利润同比 | -417.4% | -271.5% |
| 每股收益（稀释后） | $-0.09 | $-0.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCSOPA
| Q3 25 | $796.0K | $1.4M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | $2.0K | $1.9M | ||
| Q3 24 | $389.3K | $1.7M | ||
| Q2 24 | $117.1K | $1.7M | ||
| Q1 24 | $1.2K | $1.8M | ||
| Q4 23 | $2.2K | $1.7M |
净利润ABVCSOPA
| Q3 25 | $-2.0M | $-5.1M | ||
| Q2 25 | — | $479.0K | ||
| Q1 25 | — | $-1.8M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-394.8K | $-1.4M | ||
| Q2 24 | $-942.3K | $-1.9M | ||
| Q1 24 | $-2.8M | $-2.8M | ||
| Q4 23 | — | $-5.7M |
毛利率ABVCSOPA
| Q3 25 | 100.0% | 64.3% | ||
| Q2 25 | — | 56.5% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | 100.0% | 28.9% | ||
| Q3 24 | 99.9% | 21.8% | ||
| Q2 24 | 99.8% | 27.1% | ||
| Q1 24 | 77.0% | 26.7% | ||
| Q4 23 | — | 36.8% |
营业利润率ABVCSOPA
| Q3 25 | -246.8% | -379.9% | ||
| Q2 25 | — | -6.1% | ||
| Q1 25 | — | -126.6% | ||
| Q4 24 | — | -165.6% | ||
| Q3 24 | -77.7% | -70.1% | ||
| Q2 24 | -734.2% | -126.0% | ||
| Q1 24 | -235539.8% | -156.6% | ||
| Q4 23 | — | -283.1% |
净利率ABVCSOPA
| Q3 25 | -256.6% | -370.8% | ||
| Q2 25 | — | 19.1% | ||
| Q1 25 | — | -124.9% | ||
| Q4 24 | — | -217.5% | ||
| Q3 24 | -101.4% | -82.2% | ||
| Q2 24 | -804.4% | -113.3% | ||
| Q1 24 | -235203.2% | -153.8% | ||
| Q4 23 | — | -323.7% |
每股收益（稀释后）ABVCSOPA
| Q3 25 | $-0.09 | $-0.89 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $-0.44 | ||
| Q4 24 | — | $-1.03 | ||
| Q3 24 | $-0.03 | $-0.48 | ||
| Q2 24 | $-0.08 | $-0.73 | ||
| Q1 24 | $-0.29 | $-1.21 | ||
| Q4 23 | — | $-2.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $6.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $13.9M |
| 总资产 | $21.2M | $32.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABVCSOPA
| Q3 25 | $257.2K | $6.6M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | — | $7.1M | ||
| Q4 24 | $313.1K | $7.6M | ||
| Q3 24 | $208.2K | $4.2M | ||
| Q2 24 | $200.0K | $833.9K | ||
| Q1 24 | $106.4K | $1.6M | ||
| Q4 23 | $139.5K | $3.6M |
股东权益ABVCSOPA
| Q3 25 | $12.1M | $13.9M | ||
| Q2 25 | — | $2.4M | ||
| Q1 25 | — | $-663.0K | ||
| Q4 24 | $1.2M | $-2.1M | ||
| Q3 24 | $1.6M | $862.6K | ||
| Q2 24 | $1.8M | $2.4M | ||
| Q1 24 | $1.7M | $3.5M | ||
| Q4 23 | $1.6M | $5.3M |
总资产ABVCSOPA
| Q3 25 | $21.2M | $32.9M | ||
| Q2 25 | — | $29.2M | ||
| Q1 25 | — | $22.9M | ||
| Q4 24 | $7.5M | $21.3M | ||
| Q3 24 | $7.8M | $17.0M | ||
| Q2 24 | $8.0M | $13.0M | ||
| Q1 24 | $8.0M | $13.3M | ||
| Q4 23 | $7.8M | $16.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $-16.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-16.7M |
| 自由现金流率自由现金流/营收 | — | -1211.0% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABVCSOPA
| Q3 25 | $-964.7K | $-16.7M | ||
| Q2 25 | — | $-1.8M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | $-1.8M | $3.7M | ||
| Q3 24 | $60.2K | $2.0M | ||
| Q2 24 | $-211.4K | $-864.6K | ||
| Q1 24 | $-955.8K | $-2.4M | ||
| Q4 23 | $-4.2M | $-4.1M |
自由现金流ABVCSOPA
| Q3 25 | — | $-16.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $-4.2M | $-4.1M |
自由现金流率ABVCSOPA
| Q3 25 | — | -1211.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | -194367.2% | -235.8% |
资本支出强度ABVCSOPA
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 979.3% | 1.9% |
现金转化率ABVCSOPA
| Q3 25 | — | — | ||
| Q2 25 | — | -3.70× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
